Ultracet and Azelastine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ultracet (acetaminophen; tramadol hydrochloride) and Azelastine (azelastine hydrochloride). Common drug interactions include drug ineffective among females and constipation among males.

The phase IV clinical study analyzes what interactions people have when they take Ultracet and Azelastine. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Ultracet?

Ultracet has active ingredients of acetaminophen; tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 6,351 Ultracet users. Check the latest studies of Ultracet.

What is Azelastine?

Azelastine has active ingredients of azelastine hydrochloride. It is often used in allergies. eHealthMe is studying from 17,400 Azelastine users. Check the latest studies of Azelastine.

On Jul, 11, 2026

15 people who take Ultracet and Azelastine together, and have interactions are studied.

Ultracet and Azelastine drug interactions.

What are the common drug interactions of Ultracet and Azelastine, by gender? *:

female:

Drug ineffective
Asthma
Chest discomfort
Conversion disorder (neurological symptoms, such as numbness, blindness, paralysis, or fits without a definable organic cause)
Dizziness
Gingivitis (inflammation of gums)
Headache (pain in head)
Heart rate increased
Nephrolithiasis (calculi in the kidneys)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

male:

Constipation
Diarrhoea
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Pneumonia
Arthralgia (joint pain)
Asthenia (weakness)
Blood pressure increased
Capillary disorder (capillary disease)
Chills (felling of cold)

What are the common drug interactions of Ultracet and Azelastine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chest discomfort
Conversion disorder (neurological symptoms, such as numbness, blindness, paralysis, or fits without a definable organic cause)
Dizziness
Drug ineffective
Headache (pain in head)
Heart rate increased
Motion sickness (travel sickness)
Nephrolithiasis (calculi in the kidneys)
Nervous system disorder (a general class of medical conditions affecting the nervous system)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

50-59:

Arthralgia (joint pain)
Asthenia (weakness)
Blood pressure increased
Capillary disorder (capillary disease)
Chills (felling of cold)
Constipation
Diarrhoea
Disease progression
Dry skin
Dyspnoea exertional (breathlessness or shortness of breath)

60+:

Constipation
Diarrhoea
Pneumonia
Dizziness
Drug administration error
Dyspnoea (difficult or laboured respiration)
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Full blood count decreased
Pruritus (severe itching of the skin)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 26.67%
Urination - Painful: 3 people, 20.00%
Asthma: 3 people, 20.00%
Constipation: 3 people, 20.00%
Cough: 3 people, 20.00%
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 3 people, 20.00%
Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 3 people, 20.00%
High Blood Pressure: 3 people, 20.00%
Hypersensitivity: 3 people, 20.00%
High Blood Cholesterol: 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ultracet and Azelastine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously